JERUSALEM, Aug. 13 (Xinhua) -- First three Israeli COVID-19 patients were treated with plasma-based antibodies as part of clinical trials, the Hadassah Medical Center in Jerusalem said on Thursday.
The three patients showed a rapid clinical improvement and have already been discharged from the hospital, the center said.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!